Pierre Beaurang
Algemeen Directeur bij Nitrase Therapeutics, Inc.
Profiel
Pierre Beaurang is currently the Chief Executive Officer & Director at Nitrase Therapeutics, Inc. He previously worked as the Vice President-Business & Corporate Development at Nurix Therapeutics, Inc. He received his undergraduate and graduate degrees from Boston University and his doctorate from the University of California, Berkeley.
Actieve functies van Pierre Beaurang
| Bedrijven | Functie | Begin |
|---|---|---|
Nitrase Therapeutics, Inc.
 Nitrase Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nitrase Therapeutics, Inc. develops drugs against newly discovered nitration enzyme. The firm provides disease modifying drugs for multiple additional aging-dependent diseases, such as neurodegenerative disease, heart disease and cancer. The company was founded by Irene Griswold-Prenner and is headquartered in Jackson, WY. | Algemeen Directeur | 02-11-2021 |
Eerdere bekende functies van Pierre Beaurang
| Bedrijven | Functie | Einde |
|---|---|---|
| NURIX THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Opleiding van Pierre Beaurang
| Boston University | Graduate Degree |
| University of California, Berkeley | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NURIX THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Nitrase Therapeutics, Inc.
Nitrase Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nitrase Therapeutics, Inc. develops drugs against newly discovered nitration enzyme. The firm provides disease modifying drugs for multiple additional aging-dependent diseases, such as neurodegenerative disease, heart disease and cancer. The company was founded by Irene Griswold-Prenner and is headquartered in Jackson, WY. | Commercial Services |
